Vicore Pharma reports SEK 133.3 million Q3 operating loss
Vicore Pharma (NASDAQ:VCRE) reported an operating loss of SEK 133.3 million for the third quarter of 2026, while its Phase 2b ASPIRE trial continued following an independent review.
Vicore Pharma (NASDAQ:VCRE) reported an operating loss of SEK 133.3 million for the third quarter of 2026, while its Phase 2b ASPIRE trial continued following an independent review.
Crédit Mutuel Arkéa has confirmed attackers used the bank's own account to route fraudulent transfers to other financial institutions.
Polygon (POL) community members have proposed a hard fork to recover 70.49 million POL linked to the Polymarket and Binance security incidents.
Arkansas Attorney General Tim Griffin has sued Kalshi over alleged illegal gambling operations in the state.
Woodside Energy (ASX:WDS) announced plans to eliminate 500 jobs and reduce annual costs by US$570 million as part of a newly revised corporate strategy.
The New South Wales Upper House Public Accountability and Works Committee recommended 26 regulatory changes to oversee data centre developments.
The US Office of the Comptroller of the Currency (OCC) has issued new guidance covering banks' use of Super Intelligence.
Top End Energy (ASX:TEE) applied to surrender exploration permit EP 153 in the Northern Territory to concentrate resources on its EP 144 Project.
Trump Media-linked wallets transferred 4,259 Bitcoin (BTC), worth approximately $343.67 million, to Crypto.com, according to Arkham data.
Neuren Pharmaceuticals (ASX:NEU) upgraded its full-year 2026 financial guidance after partner Acadia Pharmaceuticals (NASDAQ:ACAD) reported a 39% surge in third-quarter DAYBUE net sales.
GET YOUR GRAFA EDGE NOW
We'll switch on a 30-day Edge trial as a welcome gift
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy